Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the ...

The Dow Jones Industrial Average and the S&P 500 were pressured in early trades Friday as UnitedHealth fell amid a Department of Justice probe. Blue chips were down 0.8%, or more than 350 points, ...

The global market leader Wall Street will be closed on Monday, February 17, due to the celebration of Washingtons birthday ...

The weakness was also weighing on shares of some of Walmart's rivals, as Costco Wholesale Corp.'s stock (COST) fell 2.2% and Target Corp. shares (TGT) shed 1.1%, to underperform the S&P 500 index's ...

The Fund lagged the benchmark composite index, which was up 15.01%, while the Fund underperformed the Morningstar Moderate ...

The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events. Macro data and headlines  ...

9th grade: Mckynlie Ackman, Lily Adams, Grant Alspaugh, Colton Altman, Mitchel Baker, Gordon Barks, Oren Basler, Micah Bearden, Gabrielle Bell, Liam Bergmark ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Pharmaceutical company Eli Lilly (LLY) has been raking it in lately thanks to its two flagship products: Mounjaro and Zepbound. These two have ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...